Walleye Capital LLC Lava Therapeutics Nv Transaction History

Walleye Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.57 - $2.29 $17,133 - $24,990	-10,913 Reduced 42.5%	14,762 $24,000
Q2 2024 Aug 14, 2024	SELL	$1.8 - $3.37 $232,183 - $434,699	-128,991 Reduced 83.4%	25,675 $46,000
Q1 2024 May 15, 2024	BUY	$1.53 - $4.03 $236,638 - $623,303	154,666 New	154,666 $515,000

3.45M

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $24.2M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.